10.8
CiteScore
 
5.3
Impact Factor
Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
Search in posts
Search in pages
Filter by Categories
Corrigendum
Current Issue
Editorial
Erratum
Full Length Article
Full lenth article
Original Article
Research article
Retraction notice
Review
Review Article
SPECIAL ISSUE: ENVIRONMENTAL CHEMISTRY
10.8
CiteScore
5.3
Impact Factor
Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
Search in posts
Search in pages
Filter by Categories
Corrigendum
Current Issue
Editorial
Erratum
Full Length Article
Full lenth article
Original Article
Research article
Retraction notice
Review
Review Article
SPECIAL ISSUE: ENVIRONMENTAL CHEMISTRY
View/Download PDF

Translate this page into:

Review article
03 2022
:16;
104527
doi:
10.1016/j.arabjc.2022.104527

Comprehensive chemical profiling and quantification of Shexiang Xintongning tablets by integrating liquid chromatography-mass spectrometry and gas chromatography-mass spectrometry

State Key Laboratory of Natural Medicines, School of Traditional Chinese Pharmacy, China Pharmaceutical University, No. 24 Tongjia Lane, Nanjing 210009, China
State Key Laboratory of Natural Medicines, Key Laboratory of Drug Metabolism and Pharmacokinetics, China Pharmaceutical University, No. 24 Tongjia Lane, Nanjing 210009, China

⁎Corresponding authors. liping2004@126.com (Ping Li), yanghuacpu@126.com (Hua Yang)

Disclaimer:
This article was originally published by Elsevier and was migrated to Scientific Scholar after the change of Publisher.
These authors contributed equally to this work.

Abstract

Abstract

Shexiang Xintongning tablet (SXXTN) is a traditional Chinese medicine (TCM) preparation for the treatment of coronary heart disease (CHD) angina pectoris. However, due to the complexity of the compounds in SXXTN, the active chemical components responsible for the therapeutic effect are still ambiguous. The purpose of our study was to characterize the chemical profile of SXXTN and quantify the representative chemicals. The high-performance liquid chromatography coupled with time-of-flight mass spectrometry (HPLC-QTOF MS) method and gas chromatograph coupled with mass spectrometry (GC–MS) method were utilized to identify the chemical constituents of SXXTN. A total of 140 compounds including alkaloids, ginsenosides, organic acids, esters, triterpenes, phthalides and amino acid were identified in accordance with their retention times, accurate masses and characteristic MS/MS fragment patterns. Forty-four volatile components were characterized by GC–MS through NIST database matching. In the further research of quantitative analysis, 40 non-volatile compounds and 17 volatile compounds were determined and successfully applied for detecting in 7 batches of SXXTN samples by high performance liquid chromatography coupled with triple-quadrupole tandem mass spectrometry (HPLC-QQQ MS) and gas chromatograph coupled with triple-quadrupole tandem mass spectrometry (GC-QQQ MS) in multiple reaction monitoring (MRM) mode, respectively. The quantitative methods were verified in linearity, precision, repeatability stability and recovery. The above results indicated that the established method was practical and reliable for synthetical quality evaluation of SXXTN. In addition, our study might supplement the chemical evidence for disclosing the material basis of its therapeutic effects.

Keywords

Shexiang Xintongning tablet
traditional Chinese medicine prescription
Material basis
Multi-component content determination
GC–MS
HPLC-MS
PubMed

Abbreviations

CHD

coronary heart disease

ESI

electrospray ionization

GC–MS

gas chromatograph coupled with mass spectrometry

GC-QQQ MS

gas chromatograph coupled with triple-quadrupole tandem mass spectrometry

HPLC

high-performance liquid chromatography

HRMS

high resolution mass spectrometry

HPLC-QTOF MS

high-performance liquid chromatography coupled with time-of-flight mass spectrometry

HPLC-QQQ MS

high performance liquid chromatography coupled with triple-quadrupole tandem mass spectrometry

LOD

limit of detection

LOQ

limit of quantitation

MRM

multiple reaction monitoring

OA

oleanane

PPD

20(S)-protopanaxadiol

PPT

20(S)-protopanaxatriol

RDA

Retro Diels-Alder

RSD

relative standard deviation

SXXTN

Shexiang Xintongning tablet

TCM

traditional Chinese medicine

TLC

thin-layer chromatography

TICs

typical total ion chromatograms

1

1 Introduction

Preparations of TCM formulae have been extensively utilized for clinical medication owing to their therapeutic effects on various diseases and relatively low side effects (Sun et al., 2017). Shexiang Xintongning tablet (SXXTN), a newly hospital preparation which has got a wide application in China to treat coronary heart disease angina pectoris (qi stagnation and blood stasis syndrome) and reportorial clinical studies have shown its efficacy (Shen and Lu, 2005). SXXTN comprised of Artificial Musk, Corydalis Rhizoma (Corydalis yanhusuo W. T. Wang.), Ginseng Radix et Rhizoma (Panax ginseng C. A. Mey.), Chuanxiong Rhizoma (Ligusticum chuanxiong Hort.), Styrax (Liquidambar orientalis Mill.) and Borneolum Syntheticum. All of the above crude drugs have been reported to be associated with the effect of SXXTN in the treatment of CHD. Here, Musk and Corydalis Rhizoma are reported to reduce infarct size and improve cardiac function (Li et al., 2008; Ling et al., 2010). The mechanisms of Ginseng Radix et Rhizoma in preventing coronary artery disease, myocardial hypertrophy, heart failure and arrhythmia are gradually being revealed (Zheng et al., 2012). Chuanxiong Rhizoma, Styrax and Musk have been proved to have the role of anti-myocardial ischemia (Liu et al., 2016; Wang et al., 2019; Wu et al., 2011). Besides, Borneolum Syntheticum as an adjuvant has been reported to provide new possibilities for the treatment of atherosclerosis (Zhang et al., 2017). Muscone, tetrahydropalmatine, ginsenoside, tetramethylpyrazine, cinnamic acid and borneol have been reported as important bioactive components relevant to treatment of CHD. Recently, SXXTN was revealed have the function of reducing oxidative stress-mediated damage and enhancing angiogenesis, and might play an important role in the treatment of myocardial infarction (Li et al., 2020). Obviously, the identification and detection of the main components in SXXTN is the premise and key to reveal its active ingredients. However, the chemical composition of SXXTN is complicated, having both volatile small molecules and non-volatile components such as alkaloids, organic acids and ginsenosides. In previous studies, the chemical constituents of each crude drugs in SXXTN have been reported (He et al., 2018; Zheng et al., 2018; Yang et al., 2021; Gurbuz et al., 2013; Ding et al., 2022; Sun et al., 2014), but little attention was paid to the integral chemical composition of SXXTN. Thin-layer chromatography (TLC) and high-performance liquid chromatography (HPLC) have made powerful contributions for quality control of SXXTN (Zhang et al., 2016). Nevertheless, they were preferred to assay the limited components in SXXTN with difficult access to comprehensive chemical information. Thus, new methods for chemical profiling and quantification of SXXTN are necessary to solve the limitations of the previous techniques.

Comprehensive profiling of chemical constituents in TCM preparations is still facing great challenges on separation, detection and identification due to their structural complexities and diversities. Nowadays, various chromatographic coupled with mass spectrometry techniques, such as GC–MS (Su et al., 2008) and LC-MS (Xu et al., 2015; Luo et al., 2019), are widely used in the study of TCM preparations due to their combined superiorities of high-efficient separation and high-sensitive detection for multi-components in complex samples. On one hand, HPLC-QTOF MS and GC–MS could provide molecular weights and abundant fragment information for structure identification of compounds in TCM preparations. On the other hand, tandem mass spectrometers coupled to LC or GC systems were powerful tools for high-throughput quantitative analysis of TCM preparations owing to their high-selective simultaneous detection of multiple compounds with MRM modes. Therefore, the integration of LC-MS and GC–MS was a potentially effective approach for in-depth chemical profiling and quality control of SXXTN.

In this paper, HPLC-QTOF MS and GC–MS analysis methods were established for the global characterizations of complicated non-volatile and volatile ingredients in SXXTN. Besides, considering the representative components of all relevant single drugs in SXXTN, the abundance and activity of chemicals and the availability of reference substances, 57 compounds were further quantitatively analyzed by HPLC-QQQ MS and GC-QQQ MS method. The aims of our study were comprehensively qualitative and quantitative profiling the chemical basis of SXXTN, which were expected to improve the quality control, promote the pharmacological researches and expand the clinical applications.

2

2 Materials and methods

2.1

2.1 Reagents and materials

Seven batches of SXXTN were generously provided by Shandong Hongjitang Pharmaceutical Group Co., ltd. (Shandong, China) and listed in Table S1. A total of 101 reference standards and 3 internal standards were presented in Table S2. All standards were≥98 % by HPLC and 1H NMR analyses.

Ultrapure water (18.2 MΩ cm) for analysis was prepared by a Milli-Q water purification system (Millipore, Bedford, MA, USA). Methanol and acetonitrile (HPLC grade) were provided by Merck (Darmstadt, Germany), and formic acid (HPLC grade) were purchased from ROE (Newark, New Castle, DE, USA). Ethyl alcohol (HPLC grade) was offered by Sichuan Ruijingte Technology Co., ltd. (Sichuan, China).

2.2

2.2 Standard solution and samples preparations

The reference standards were solubilized by 75 % methanol-aqueous solution (v/v) to obtain 1.00 mg/mL reserve solution and diluted with appropriate solvent to a range of proper concentrations.

In qualitative analysis, for LC-MS, the SXXTN was ground into powder. SXXTN powder (0.3003 g) was accurately weighed and ultrasonic extracted (40 kHz, 500 W) with 5 mL 75 % methanol-aqueous solution (v/v) for 30 min. The extracts were centrifuged (13,000 rpm, 10 min, 4℃) before LC-MS analysis. For GC–MS, the powder (0.3000 g) was accurately weighed, then sonicated for 30 min at 40 kHz with 5 mL of ethanol. The filtrate was filtered by 0.45 μm filter membrane and centrifuged before sampling.

For quantitative analysis, to determine the non-volatile constituents, each batch of SXXTN powder (0.3 g) was weighed in three parallel times, then ultrasonic extracted (40 kHz, 500 W) with 5 mL 75 % methanol for 30 min. The filtrate was filtered by 0.45 μm filter membrane and centrifuged (13000 rpm, 10 min, 4℃). For alkaloids quantification (group A, 24 alkaloids), the supernatant was diluted after adding proper nitidine chloride (IS1, 1.11 μg/mL) as internal standard. For ginsenosides and acids quantification (group B, 14 ginsenosides, cinnamic acid and phenylalanine), the supernatant was diluted after proper saikosaponin C (IS2, 0.985 μg/mL) adding. To determine the volatile constituents, about 0.3 g the powder of SXXTN was extracted with 10 mL ethanol under ultrasonic conditions in ice-water bath for 20 min. The extraction was filtered through syringe filter (0.45 μm) and centrifuged. Isoborneol, borneol, 3-phenylpropyl cinnamate and cinnamyl cinnamate possessed significantly higher abundances in SXXTN comparing with other volatile components, indicating the large differences of contents among various compounds. Therefore, the supernatant was diluted 10 times before injecting to GC–MS for quantitative analysis of high-abundant volatile compounds (Group D), whereas directly injected for others with relatively low-abundances (Group C). And a certain amount of naphthalene (IS3, 23.2 μg/mL) was added to the supernatants as internal standard.

2.3

2.3 HPLC-QTOF MS analysis conditions

Agilent 1290 HPLC system (Agilent corporation, USA) was used to determine the non-volatile components of SXXTN. A ZORBAX Eclipse Plus C18 column (150 × 2.1 mm, 1.8 μm, Agilent Technologies, Santa Clara, USA) was used for sample separation. The mobile phase consisted of 0.1 % (v/v) formic acid in water (A) and acetonitrile (B) with the gradient elution set as follows: 0–3 min, 10 %-12 % B; 3–8 min, 12 %-17 % B; 8–20 min, 17 %–22 % B; 20–30 min, 22 %-35 % B; 30–45 min, 35 %-42 % B; 45–50 min, 42 %-60 % B; 50–57 min, 60 % B; 57–60 min, 60 %-80 % B; 60–68 min, 80 %-100 %. The flow rate was set at 0.4 mL /min, and the column temperature was maintained at 30 ℃. Sample volume was 1 μL for injection.

The Q-TOF mass spectrometer equipped with electrospray ionization (ESI) source was used to acquire data in positive and negative ion modes. The operation conditions were as below: drying gas (N2) temperature, 300 ℃; drying gas flow, 8.0 L/min; nebulizer gas (N2) pressure, 35 psig; sheath gas (N2) temperature, 350 ℃; sheath gas flow, 11.0 L/min; capillary voltage positive ion mode, 4000 V; negative ion mode, 3500 V; fragmentor voltage, 120 V; skimmer voltage, 65 V. Full-scan MS and MS/MS data was collected over the m/z range of 50–1500 using extended dynamic range. Collision energy of secondary mass spectrometry was set as 15 eV, 30 eV and 45 eV.

2.4

2.4 GC–MS analysis conditions

Compound identification was performed by Agilent 7890B GC system combined with Agilent 5977 Mass Selection Detector. Samples were separated by Agilent HP-5MS (30 m × 0.25 mm, 0.25 μm) column. The carrier gas was high purity helium, and the flow rate was 1 mL/min. Initial column temperature was 60 ℃, and programmed to rise at 20 °C/min to 85 °C (1 min held), 5 ℃/min to 100 ℃ (5 min held), 15 ℃/min to 150 ℃ (6 min held), 5 ℃/min to 200 ℃ (4 min held), rising at 5 ℃/min to 280 ℃ (5 min held). The injection volume was 1 μL and the splitting ratio was 30:1. The temperature of injector and aux heaters was controlled at 250℃ and 280℃, respectively. MS quadrupole and ion source temperature were maintained at 150℃ and 230℃, severally. MS data were recorded at 70 eV and acquired in full scan mode over the range of m/z 40–600.

2.5

2.5 HPLC-QQQ MS analysis conditions

The quantitative analysis was performed on the Shimadzu LCMS-8050 triple quadrupole tandem mass spectrometry detector (Shimadzu, Kyoto, Japan) with an Agilent Zorbax Eclipse Plus C18 column (2.1 × 150 mm, 1.8 µm, Agilent Technologies, Santa Clara, USA). For group A, 0.1 % (v/v) formic acid water (A) and acetonitrile (B) were used as mobile phases, and the gradient elution procedure was as follows: 0–12 min, 19 %-20 % B; 12–14 min, 20 %-35 % B; 14–16 min, 35 %-90 % B; 16–19 min, 90 %-100 % B. For group B, the mobile phase was water (A) and acetonitrile (B), with the following gradient elution: 0–3 min, 10 %-12 % B; 3–6 min, 12 %-35 % B; 6–14 min, 35 %-36.5 % B 14–15 min, 36.5 %-90 % B; 15–19 min, 90 %-100 % B. The flow rate was maintained at 0.4 mL/min, with the injection volume 2 μL for all samples. The MS conditions were as below: capillary voltage, 4000 V; drying gas temperature, 300 °C. The flow rate of drying gas (N2) and nebulizer gas (N2) was 10.0 L/min and 3.0 L/min, severally. Analytes were determined in MRM modes, and the optimized parameters were shown in Table S3 and S4.

2.6

2.6 GC-QQQ MS analysis conditions

The quantitative analysis of volatile components was operated on an Agilent 7890B gas chromatography coupling to Agilent 5977A mass spectrometry (Agilent, Santa Clara, CA, USA). For group C, the initial column temperature was 60 ℃, and programmed to rise at 20 °C/min to 85 °C, 5 ℃/min to 100 ℃ (5 min held), 15 ℃/min to 150 ℃, 5 ℃/min to 180 ℃ (1 min held), finally rising at 15 ℃/min to 280 ℃ (2 min held). For group D, the initial column temperature was set at 100 ℃, and programmed to rise at 10 °C/min to 110 °C, 3 ℃/min to 120 ℃, 55 ℃/min to 265 ℃, finally rising at 18 ℃/min to 280 ℃ (2 min held). The injection volume was 1 μL and the splitting ratio was 10:1. The MRM parameters for all analytes are presented in Table S5 and S6. Other analytical conditions refer to Section 2.4.

3

3 Results and discussion

3.1

3.1 Qualitative analysis of SXXTN based on diagnostic ion strategy by HPLC-QTOF MS

The HPLC-QTOF MS conditions of the mobile phase systems (methanol-aqueous, acetonitrile-aqueous, and acetonitrile-aqueous with 0.1 % formic acid), gradient program, column temperature (25 °C, 30 °C, and 35 °C) and the flow rate (0.2, 0.3 and 0.4 mL/min) were optimized in order to obtain overall constituents of SXXTN with good resolution within a short analysis. The total peak area was adopted as a criterion for optimization. Ultimately, the optimum conditions mentioned in Section 2.3 were preferred.

Diagnostic ion strategy is regarded as a powerful approach for rapid characterization of chemicals in TCMs based on the principle that similar chemical constituents have similar cleavage rules and the fragmentation information, which is applicable for the identification of structural analogues in complex TCMs and formulae (Wang et al., 2017). In our study, by comparing with the reference standards, the known compounds were marked. On the basis of MS/MS analysis of authentic compounds, the characteristic fragmentation pathways of compounds with the same carbon skeleton were presented, the obtained rules were further applied to the structural characterization of its derivatives. For other unknown compounds, identification based on MS/MS spectra and relevant literature or online databases, including PubChem search ( https://pubchem.ncbi.nlm.nih.gov/) and the Human metabolome database ( https://www.hmdb.ca/). The typical total ion chromatograms (TICs) of SXXTN by HPLC-QTOF MS in both of positive and negative ion modes were displayed in Fig. 1. Totally, 140 compounds were identified based on diagnostic ion strategy, including 60 alkaloids, 34 ginsenosides, 21 organic acids, 12 phthalides, 10 triterpenes, 2 esters and 1 amino acid. The chemical structures and detailed information of compounds could be viewed in Fig. 2 and Table 1, respectively. The MS/MS spectra and fragmentation pathways of the representative chemicals were shown in Fig S1 and Fig S2.

Total ion current chromatograms of SXXTN in positive ion mode (A) and negative ion mode (B) by HPLC-QTOF MS.
Fig. 1
Total ion current chromatograms of SXXTN in positive ion mode (A) and negative ion mode (B) by HPLC-QTOF MS.
Structures of chemical constituents from SXXTN.
Fig. 2
Structures of chemical constituents from SXXTN.
Structures of chemical constituents from SXXTN.
Fig. 2
Structures of chemical constituents from SXXTN.
Structures of chemical constituents from SXXTN.
Fig. 2
Structures of chemical constituents from SXXTN.
Table 1 Characterization of chemical constituents of SXXTN by HPLC-QTOF MS.
No. tR
(min)
Formula Precursorions (m/z) Diff (ppm) Fragment ions
(m/z)
Identification Structural Types
1 0.88 C5H14NO+ 104.1069 [M + H]+ −0.87 58.0658,60.0813 Choline Alkaloid
2* 1.06 C4H6O5 133.0143 [M−H]- 0.40 115.0036,89.0252,71.0148 Malic acid Organic acid
3 1.33 C4H6O4 117.0192 [M−H]- −1.13 99.9252,73.0303 Succinic acid Organic acid
4* 1.46 C6H11NO2 130.0867 [M + H]+ 3.42 70.0653,84.0814,56.0510 Dl-pipecolinic acid Organic acid
5* 1.56 C9H11NO2 166.0864 [M + H]+ 0.87 120.0806,103.0547 Phenylalanine Amino acid
6* 3.28 C8H12N2 137.1067 [M + H]+ −4.50 55.0550,80.0475 Tetramethylpyrazine Alkaloid
7 3.74 C16H18O9 353.087 [M−H]- −2.28 191.0562,179.0339 Neochlorogenic acid Organic acid
8* 3.89 C7H6O3 137.024 [M−H]- −3.05 93.0348,65.0413 4-Hydroxybenzoic acid Organic acid
9 4.07 C19H24NO3 314.1755 [M]+ 1.37 269.1173,175.0748,107.0491 Magnocurarine Alkaloid
10* 4.22 C16H18O9 353.0901 [M−H]- 6.50 191.0563,179.0364,173.0456 Chlorogenic acid Organic acid
11* 4.75 C8H8O4 167.0341 [M−H]- −5.28 152.3304,123.0429,108.0130 Vanillic acid Organic acid
12* 5.04 C9H8O4 179.0352 [M−H]- 1.22 135.0458 Caffeic acid Organic acid
13 5.69 C19H21NO4 328.1547 [M + H]+ 1.11 265.0853,297.1108,282.0882,165.0713 Isoboldine Alkaloid
14 5.71 C7H6O2 121.0291 [M−H]- −3.33 92.0281,76.9491 Benzoic acid Organic acid
15 7.04 C8H8O2 135.0456 [M−H]- 3.31 120.0225,92.0278 Phenylacetic acid Organic acid
16 7.07 C19H24NO4 330.1702 [M]+ 0.65 299.1269,192.1032,175.0186,
143.0016
Reticuline Alkaloid
17 7.44 C19H19NO4 326.1386 [M + H]+ −0.26 295.0969,263.0696,235.0752 Bulbocapnine Alkaloid
18 7.66 C19H24NO3 314.1759 [M]+ 2.64 269.1173,237.0907,175.0745,
107.0490
Lotusine Alkaloid
19 7.71 C9H8O3 163.0402 [M−H]- 0.81 119.0497 4-Hydroxycinnamic acid Organic acid
20 7.92 C19H24NO3 314.1743 [M]+ −2.45 237.0885,209.0961,107.0488 Oblongine Alkaloid
21* 8.13 C19H21NO4 328.1549 [M + H]+ 1.72 178.0862,163.0627,151.0755 Scoulerine Alkaloid
22 8.39 C20H23NO4 342.1697 [M + H]+ −0.83 178.0856,326.1402 Corytenchine Alkaloid
23* 8.83 C20H23NO4 342.1699 [M + H]+ −0.25 279.1015,311.1278,342.1699 Isocorydine Alkaloid
24 9.06 C19H19NO4 326.1393 [M + H]+ 1.89 178.0854,151.0730 Cheilanthifoline Alkaloid
25 9.10 C18H21NO3 300.1596 [M + H]+ 0.60 269.1175,237.0921,192.1025 N-Methylcoclaurine Alkaloid
26* 9.19 C10H10O4 193.0505 [M−H]- −0.69 178.0277,149.0594,134.0374 Ferulic acid Organic acid
27 9.21 C20H23NO4 342.1698 [M + H]+ −0.54 192.1020,148.0753 Lirioferine Alkaloid
28* 9.36 C20H23NO4 342.1700 [M + H]+ −0.25 327.1472,165.0909,192.1016 Corydalmine Alkaloid
29* 10.57 C20H23NO4 342.1707 [M + H]+ 2.09 327.1472,326.1414,178.0866 Tetrahydrocolumbamine Alkaloid
30 11.02 C21H25NO4 356.1856 [M + H]+ −0.10 341.1609,326.1389,308.1276,
192.1020,177.0783
N-Methyltetrahydropalmatrubie Alkaloid
31 11.24 C19H16NO4 322.1074 [M + H]+ −2.57 307.0839,294.2059,279.0888 Berberrubine Alkaloid
32 11.29 C21H25NO4 356.1857 [M + H]+ 0.18 341.1617,326.1390,192.1018,
165.0909,150.0672
N-Methylcorydalmine Alkaloid
33* 11.35 C20H23NO4 342.1695 [M + H]+ −1.42 326.1387,178.0860,163.0629,
151.0725,119.0489
Corypalmine Alkaloid
34 11.83 C21H25NO4 356.1860 [M + H]+ 1.03 341.1590,326.1380,308.1283,192.1020 N-Methylcorypalmine Alkaloid
35 12.26 C20H23NO5 358.1652 [M]+ 0.84 356.1856,340.1516 Capaurimine Alkaloid
36* 12.41 C20H19NO5 354.1343 [M + H]+ 1.98 336.1229,206.0812,189.0777,275.0705 Corydinine Alkaloid
37* 12.45 C19H18NO4+ 324.1228 [M]+ −0.72 307.9500,280.0005,309.0006 Demethyleneberberine Alkaloid
38 13.17 C20H21NO4 340.1538 [M + H]+ −1.57 324.1229,309.1100,296.1274 Sinactine Alkaloid
39 13.41 C21H25NO4 356.1855 [M + H]+ −0.38 341.1632,340.1554,326.1415 Corybulbine Alkaloid
40 13.58 C25H24O12 515.118 [M−H]- −2.91 353.0853,191.0556 Isochlorogenic acid A Organic acid
41 13.84 C25H24O12 515.1182 [M−H] - −6.14 353.0867,191.0541 Isochlorogenic acid B Organic acid
42 14.20 C20H20NO4+ 338.1390 [M]+ 0.93 322.1055,380.0926,294.1122,280.0937 Tetrahydrocorysamine Alkaloid
43* 14.40 C20H23NO4 342.1679 [M + H]+ −0.25 325.1432,294.1250,279.1035,251.1113 Norglaucine Alkaloid
44* 14.54 C21H23NO5 370.1659 [M + H]+ 2.70 188.0706,290.0939,321.1141,352.1548 Allocryptopine Alkaloid
45 14.79 C12H14O3 207.1016 [M + H]+ 0.14 189.0893,175.0196,123.0433,67.0544 4-Hydroxy-3-butylphthalide Phthalide
46* 14.93 C21H25NO4 356.1846 [M + H]+ −2.91 294.1254,310.1206,325.1436 Glaucine Alkaloid
47* 14.96 C19H17NO4 324.1243 [M + H]+ 2.05 176.0713,294.1251,149.0579, Tetrahydrocoptisine Alkaloid
48* 15.04 C21H25NO4 356.1879 [M + H]+ 2.71 192.1032,165.0918,194.1271,326.1479 Tetrahydropalmatine Alkaloid
49 15.09 C20H25NO3+ 328.1916 [M + H]+ 2.68 283.1348,251.1070,236.0850 6-O-methylotusine Alkaloid
50* 15.36 C21H25NO4 356.1856 [M + H]+ −0.38 354.1478,325.1338,194.2615 Yuanhunine Alkaloid
51 15.75 C22H27NO4 370.2008 [M + H]+ −1.31 354.1693,206.1174,190.0871,165.0900 N-Methyltetrahydropalmatine Alkaloid
52* 15.79 C19H14NO4+ 320.0926 [M]+ 2.70 292.0972,262.0880,234.0919 Coptisin Alkaloid
53* 15.90 C20H20NO4+ 338.1395 [M]+ 2.41 323.1142,322.1015 Columbamine Alkaloid
54 16.36 C25H24O12 515.1167 [M−H]- −5.44 353.0848,191.0513 Isochlorogenic acid C Organic acid
55* 16.58 C20H20NO4+ 338.1390 [M]+ 0.93 323.1167,294.1143,322.1093 Jatrorrhizine Alkaloid
56 16.70 C12H14O3 207.1015 [M + H]+ −0.34 189.0818,161.0967 Senkyunolide F Phthalide
57 17.10 C12H14O5 237.0753 [M−H]- −6.53 193.0849,108,0193 Trimethoxycinnamic acid Organic acid
58* 17.16 C20H21NO4 340.1556 [M + H]+ 3.72 176.0716,149.0608 Canadine Alkaloid
59 17.93 C21H24NO4+ 354.1708 [M]+ 2.30 165.0906,190.0876 N-Methylcanadine Alkaloid
60* 18.03 C22H27NO4 370.2023 [M + H]+ 2.74 355.1790,192.1032,176.0731,165.0912 Corydaline Alkaloid
61 18.86 C21H22NO4+ 352.1543 [M]+ −0.10 337.1308,322.1064,309.1345,293.1041 13-Methylcolumbamine Alkaloid
62 19.38 C21H22NO4+ 352.1550 [M]+ 1.89 337.1322,322.1101,336.1254 Dehydrocorybulbine Alkaloid
63* 19.45 C48H82O19 1007.538[M + COOH]- −5.16 961.5223,799.4737,637.4235,475.3723 20-O-glucoginsenoside Rf Ginsenoside
64* 19.58 C20H16NO4+ 334.1069 [M]+ 0.35 291.0887,261.0785,147.0680 Worenine Alkaloid
65 20.73 C20H22NO5+ 356.1503 [M]+ 2.95 338.1383,322.1085,308.1241,192.0662,
164.0828,149.0594
Pseudotetrahydropalmatine Alkaloid
66* 20.73 C9H8O2 147.0447 [M−H]- −3.08 119.0485,117.0334,103.0543 Cinnamic acid Organic acid
67* 20.78 C47H80O18 977.5267 [M + COOH]- −6.11 931.5112,799.4755,637.4223,475.3682 Notoginsenoside R1 Ginsenoside
68* 21.28 C9H10O3 165.0562 [M−H]- 2.92 137.0213,92.0268 Ethylparaben Ester
69 21.37 C22H27NO5 386.1955 [M + H]+ −1.81 368.1833,190.0847,178.0980 Muramine Alkaloid
70* 21.58 C20H18NO4 336.1237 [M]+ 1.98 321.1008,306.0783,320.0931 Berberine Alkaloid
71* 21.96 C21H22NO4+ 352.1551 [M]+ 2.17 337.1324,322.1101,308.1302,294.1139,
279.0938
Palmatine Alkaloid
72 22.23 C22H26NO4+ 368.1836 [M]+ −5.35 352.1524,338.1259,192.0987 Tetrahydroprotoberberine Alkaloid
73* 22.90 C42H72O14 845.4884 [M + COOH]- −2.38 799.4690,637.4205,475.3705,161.0433 Ginsenoside Rg1 Ginsenoside
74* 23.09 C48H82O18 991.545 [M + COOH]- −3.35 945.5269,783.4777,637.4213,475.3705 Ginsenoside Re Ginsenoside
75* 24.01 C22H24NO4 366.1705 [M]+ 1.41 351.1488,350.1417,336.1260 Dehydrocorydaline Alkaloid
76* 24.47 C21H20NO4+ 350.1379 [M]+ −2.24 334.1062,306.1124,320.0961 13-Methylberberine Alkaloid
77 25.01 C22H24NO4+ 366.17 [M]+ −0.91 336.1226,351.1454 13-Methoxyberberine Alkaloid
78 25.24 C19H14NO4+ 320.0922 [M]+ 1.45 292.0947,262.0843,234.0893 Coptisin isomer Alkaloid
79 25.51 C20H18NO5+ 352.1197 [M]+ 4.97 336.0877,322.0695,306.0756,292.0591 13-Oxoberberine Alkaloid
80* 28.91 C42H72O14 845.4891 [M + COOH]- −1.55 799.4723,637.4220,475.3721,161.0441 Ginsenoside Rf Ginsenoside
81* 29.69 C59H100O27 1239.6357 [M−H]- −1.79 1107.5968,1077.5859 Notoginsenoside R4 Ginsenoside
82* 29.90 C41H70O13 815.4785 [M + COOH]- −1.65 769.4610,637.4229,475.3727,
161.0449,391.2853
Notoginsenoside R2 Ginsenoside
83* 30.84 C42H72O13 829.4945 [M + COOH]- −1.20 783.4794,637.4245,475.3739,
391.2800,161.0439
20(S)-Ginsenoside Rg2 Ginsenoside
84* 30.93 C58H98O26 1245.6046 [M + Cl]- 0.45 1209.6246,1077.5795 Ginsenoside Ra2 Ginsenoside
85* 31.18 C59H100O27 1239.6358 [M−H]- −1.17 1107.8589,864.3445,783.5100 Ginsenoside Ra3 Ginsenoside
86* 31.19 C54H92O23 1107.5962 [M−H]- 0.49 945.5333,783.4762,179.0540 Ginsenoside Rb1 Ginsenoside
87 31.66 C57H94O26 1193.594 [M−H]- −1.72 1159.5908,1107.5793,1089.5701,
945.5294
Malonylginsenoside Rb1 Ginsenoside
88* 31.92 C53H90O22 1123.5884 [M + COOH]- −1.94 1077.5685,945.5308,784.4864 Ginsenoside Rc Ginsenoside
89* 31.92 C58H98O26 1245.6046 [M + Cl]- 0.45 1209.6278,945.5503 Ginsenoside Ra1 Ginsenoside
90* 32.14 C48H76O19 955.4849 [M−H]- −6.18 793.4271,631.3664,523.3719,455.3456 Ginsenoside Ro Ginsenoside
91 32.39 C61H100O29 1295.6251 [M−H]- −2.05 1251.6282,1209.6131,1191.6035,
1059.5610
Malonylginsenoside Ra1/Ra2 Ginsenoside
92 32.47 C56H92O25 1163.5837 [M−H]- −1.54 1119.5849,1077.5763,1059.5647,
927.5217
Malonylginsenoside Rb2 Ginsenoside
93* 32.77 C53H90O22 1123.5874 [M + COOH]- −2.83 783.4804,945.5378,149.0458 Ginsenoside Rb2 Ginsenoside
94* 33.09 C53H90O22 1113.5633 [M + Cl]- 1.37 1077.4828,945.5401,783.4882,
621.4349
Ginsenoside Rb3 Ginsenoside
95 33.37 C56H92O25 1163.5826 [M−H]- −2.56 1119.5877,1077.5761,1059.5664 Malonylginsenoside Rc Ginsenoside
96* 33.50 C47H74O18 925.4793 [M−H]- −1.01 763.4258,569.3849 Pseudoginsenoside RT1 Ginsenoside
97 33.72 C56H92O25 1163.5808 [M−H]- −4.03 1119.5819,1077.5723,1059.5612,
927.5204
Malonylginsenoside Rb2/Rc isomer Ginsenoside
98 33.90 C56H94O24 1185.5829 [M + Cl]- 0.00 1149.6073,1107.5942,1089.5846 Quinquenoside R1 Ginsenoside
99 34.23 C21H22NO5+ 368.1492 [M]+ −4.21 353.1250,338.1017,336.1226 Corynoline Alkaloid
100 34.84 C56H92O25 1163.5859 [M−H]- 0.35 1119.5911,1077.5854,783.4934 Malonylginsenoside Rb2/Rc isomer Ginsenoside
101* 34.94 C48H82O18 991.5454 [M + COOH]- −3.35 945.5265,783.4762,621.4260,459.3774 Ginsenoside Rd Ginsenoside
102 35.12 C55H92O23 1119.5956 [M−H]- −0.06 1077.5746,1059.5686,937.1230 Ginsenoside RS2 Ginsenoside
103 35.17 C21H19NO6 382.1282 [M + H]+ −0.82 336.0869,308.0974,265.0691 Pontevedrine Alkaloid
104 35.65 C51H84O21 1031.5382 [M−H]- −4.88 987.5375,945.5286,927.5203,
783.4779,765.4668
Malonyl Ginsenoside Rd Ginsenoside
105 35.86 C22H24NO4+ 366.1687 [M]+ −3.51 350.1374,336.1240,322.1413,308.1290 Dehydrocorydaline isomer Alkaloid
106* 37.22 C48H82O18 991.547 [M + COOH]- −1.33 945.5397 Gypenoside XVII Ginsenoside
107* 37.95 C19H13NO5 336.0869 [M + H]+ 0.75 308.0913,293.0668,250.0864 8-Oxycoptisine Alkaloid
108* 38.05 C12H16O2 193.1228 [M + H]+ 2.56 105.0706,137.0609,147.1169 Senkyunolide A Phthalide
109 39.48 C22H24NO4+ 366.1695 [M]+ −1.32 350.1388,336.1237,322.1447,308.1251 Dehydrocorydaline isomer Alkaloid
110* 39.70 C12H14O2 191.1066 [M + H]+ −0.29 135.0455,145.1003 Butylphthalide Phthalide
111* 42.85 C12H14O2 191.1059 [M + H]+ −3.96 145.1010,173.0957,117.0695 (E)-Ligustilide Phthalide
112 43.70 C36H60O8 665.4265 [M + COOH]- −0.78 655.3976,569.2387,327.1338 Ginsenoside Rk3/Rh4 Ginsenoside
113* 45.28 C12H18O2 195.1382 [M + H]+ 1.25 177.1269,149.1309,125.0595 Sedanolide Phthalide
114* 45.71 C42H66O14 793.4335 [M−H]- −5.65 613.3633,523.3703,455.3451 Zingibroside R1 Ginsenoside
115* 45.95 C12H14O2 191.1073 [M + H]+ −1.34 145.1008,173.0960,112.9674,117.0694 (Z)-Ligustilide Phthalide
116* 47.90 C42H72O13 829.4918 [M + COOH]- −4.45 783.4861,621.4345,113.0268, 459.3739,161.0423 20(S)-Ginsenoside Rg3 Ginsenoside
117 48.02 C42H66O14 793.4377 [M−H]- −0.35 613.3632,569.3760,455.3473 Zingibroside R1 isomer Ginsenoside
118* 48.22 C42H72O13 819.4670 [M + Cl]- 0.37 783.4903,621.4341,459.3756 20(R)-Ginsenoside Rg3 Ginsenoside
119 50.05 C18H18O3 281.118 [M−H]- 1.71 163.0350.145.0262,117.0316 Isoeugenyl phenylacetate Ester
120* 52.84 C21H19NO4 350.1385 [M + H]+ −0.53 335.1146,319.1191,334.1083 Dihydrochelerythrine Alkaloid
121 52.94 C30H47O4- 471.3487 [M]- 1.52 393.3162,71.0506 2-Hydroxyoleanolate or isomer Triterpene
122 53.96 C24H30O4 383.2227 [M + H]+ 2.65 191.1063,149.0599 Senkyunolide P or isomer Phthalide
123* 54.68 C20H15NO4 334.1097 [M + H]+ 0.65 319.0841,304.0967,279.1013 Dihydrosanguinarine Alkaloid
124 56.19 C24H30O4 383.2211 [M + H]+ −1.53 191.1063,149.0597 Senkyunolide P or isomer Phthalide
125 56.57 C30H47O4- 471.3480 [M]- 0.03 359.2921,162.8327 2-Hydroxyoleanolate or isomer Triterpene
126* 57.08 C24H28O4 381.2059 [M + H]+ −0.36 191.1075,173.0972,279.1508 Tokinolide B Phthalide
127* 58.38 C24H28O4 381.2070 [M + H]+ 2.53 191.107,267.1386,141.1136 Riligustilide Phthalide
128* 58.55 C24H28O4 381.2069 [M + H]+ 2.27 191.107,141.1136 Angelicide Phthalide
129 60.63 C30H46O4 469.3316 [M−H]- −1.56 305.1903,164.8363 Glycyrrhetic acid or isomer Triterpene
130* 61.18 C30H48O3 455.3528 [M−H]- −0.59 410.3532 Oleanolic acid Triterpene
131 61.28 C30H46O4 469.3314 [M−H]- −1.99 423.3197,211.1525 Glycyrrhetic acid or isomer Triterpene
132* 63.34 C18H32O2 279.2327 [M−H]- −0.91 261.2193,59.0146 Linoleic acid Organic acid
133 63.59 C30H46O3 453.3376 [M−H]- 0.40 407.3308,325.2544,100.9336 Oleanonic acid or isomer Triterpene
134 64.04 C30H46O3 453.3376 [M−H]- 0.40 407.3316,97.0653 Oleanonic acid or isomer Triterpene
135 64.08 C30H46O3 453.3374 [M−H]- −0.04 407.3316,97.0661 Oleanonic acid or isomer Triterpene
136 64.31 C30H46O3 453.3380 [M−H]- 1.28 407.3244,97.0693 Oleanonic acid or isomer Triterpene
137 64.58 C30H46O4 469.3319 [M−H]- −0.92 336.1460,141.8654 Glycyrrhetic acid or isomer Triterpene
138* 64.76 C16H32O2 255.2329 [M−H]- −0.21 237.2247,116.9283 Palmitic acid Organic acid
139* 65.26 C18H34O2 281.2490 [M−H]- 1.41 116.9279 Oleic acid Organic acid
140* 67.38 C18H36O2 283.2622 [M−H]- −7.25 265.2464,211.6753,141.7728 Octadecanoic acid Organic acid
Compared with a reference standard.

3.1.1

3.1.1 Identification of alkaloids in SXXTN

Sixty alkaloids in SXXTN demonstrated quasi-molecular ions [M + H]+ or [M]+ in positive ion mode and listed in Table 1, mostly originated from Corydalis Rhizoma and identified as four main types, including tetrahydroproberberines, berberines, protopines and aporphines.

A total of 19 tetrahydroprotoberberine-type (21, 22, 24, 28, 29, 33, 34, 35, 38, 39, 42, 47, 48, 50, 51, 58, 59, 60, 72) and 3 protopine-type alkaloids (36, 44, 69) were tentatively identified or unambiguously characterized with the characteristic cleavage pathway of Retro Diels-Alder (RDA) reaction, which can be used to distinguish them from other types of alkaloids (Yuan et al., 2016). In MS/MS of tetrahydropalmatine (48) shown as Fig. S1A, the fragment ion with the strongest intensity was located at m/z 192.1019 [M + H-C10H12O2]+, and it was found that the complementary fragment ion m/z 165.0909 [M + H-C11H13NO2]+ was corresponding to the RDA reaction of C ring. The detailed fragmentation pathways of tetrahydropalmatine (48) were displayed in Fig. S2A. For protopine-type alkaloids, C-14 position is linked to oxygen to form carbonyl, which is easy to dehydrate and forms stable fragment ions, thus distinguishing it from tetrahydroberberberine-type alkaloids (Yuan et al., 2016). Taking protopine (36) as an example (Fig. S1B), the product ions at m/z 336.1232 [M + H-H2O]+and m/z 188.0709 [M + H-C9H8O2-H2O]+ may be formed by neutral losses of H2O from molecular ions and m/z 206.0813 (Fig. S2B).

Fifteen protoberberine-type (31, 32, 37, 52, 53, 55, 61, 62, 64, 70, 71, 75, 76, 77, 79) and six aporphine-type alkaloids (13, 17, 23, 27, 43, 46) were identified in SXXTN with the cleavage pathway based on the fragmentation of substituents (Yuan et al., 2016) as displayed in Fig. S2C. For protoberberine-type alkaloids, usually losing 15 Da (–CH3) substituent as see in MS/MS spectrum (Fig. S1C) of berberine (70), the main product ions appeared at m/z 320.0919 [M−CH4]+ and m/z 321.0978 [M−CH3]+. In addition, the successive losses of CH3 and CO were the characteristic cleavage pathway of this alkaloid. For aporphine-type alkaloids, the fragment ions with the highest relative abundance usually appear when the methoxy group at 31 Da is lost. For example, fragment ion m/z 297.1108 [M + H-OCH3]+ was found in isoboldine (13), showing a loss of 31 Da (–OCH3). Due to the loss of NH2CH3 (Fig. S2D), a crucial characteristic ion at m/z 325.1445 was obtained in glaucine (46) (Fig. S1D).

3.1.2

3.1.2 Identification of ginsenosides in SXXTN

A total of 34 ginsenosides in SXXTN were displayed in Table 1, mostly from Ginseng Radix et Rhizoma and demonstrated quasi-molecular ions [M−H]- or [M + COOH]- in negative ion mode due to formic acid in the mobile phase. Based on their aglycone, ginsenosides can be classified into three main categories: 20(S)-protopanaxadiol (PPD), 20(S)-protopanaxatriol (PPT) and oleanane type (OA) saponin.

19 PPD-type ginsenosides (81, 84, 85, 86, 87, 88, 89, 91, 92, 93, 94, 95, 98, 101, 102, 104, 106, 116, 118) were characterized and prone to produce [20(S)-protopanaxadiol-H]- (C30H51O3) characteristic aglycone fragment ions at m/z 459.38 (Yang et al., 2021). For example, in MS/MS spectrometry (Fig. S1E), Compound 101 gave abundant ion at m/z 783.4762 ([M−H−Glc]-), m/z 621.4260 ([M−H−2Glc]-) and m/z 459.3774 ([20(S)-protopanaxadiol-H]-, C30H51O3), resulting from sequential eliminations of sugar residues (Fig. S2E). A total of 7 PPT-type ginsenosides (63, 67, 73, 74, 80, 82, 83) were tentatively identified and clearly marked with characteristic ions at m/z 475.37 ([20(S)-protopanaxatriol-H]-, C30H51O4) (Yang et al., 2021). As presented in Fig. S1F and Fig. S2F, ginsenoside Rg1 (73) produced abundant characteristic ions including m/z 673.4209 ([M−H−Glc]-) and m/z 475.3713 ([(20(S)-protopanaxatriol-H]-). Three OA-type ginsenosides (90, 96, 114) were unambiguously elucidated as ginsenoside Ro, pseudoginsenoside RT1 and zingibroside R1 by comparison with reference standards with characteristic ions at m/z 455.35 ([Oleanolicacid-H]-, C30H47O3) (Yang et al., 2021) as shown in MS/MS spectrum (Fig. S1G) of ginsenoside Ro (90). The fragmentation pathways were shown in Fig. S2G.

Aglycones can be identified by discovering diagnostic ions and neutral loss can be observed to determine the number and type of glycosidic bond cleavage of ginsenosides. As shown in Fig. S1H, ginsenoside Rb2 (93) appeared m/z 945.5378 ([M−H−Ara]-) and m/z 783.4803 ([M−H−Ara−Glc]-) in MS/MS spectrum.

3.1.3

3.1.3 Identification of organic acids in SXXTN

In total, 21 organic acids (2, 3, 4, 7, 8, 10, 11, 12, 14, 15, 19, 26, 40, 41, 54, 57, 66, 132, 138, 139, 140) were identified from SXXTN and shown in Table 1. Organic acids were easy to generate fragment ions in MS/MS with losing CO, CO2, –COOH, H2O, etc. (Yan, Wang, 2014). For example, fragment ions m/z 178.0273 [M−H−CH3]-, m/z 149.0561 [M−H−CO2]-, m/z 134.0371 [M−H−CH3−CO2]- and m/z 160.8423 [M−H−CH3−H2O]- were observed in secondary mass spectrometry of ferulic acid (26) (Fig. S1I) following specific cleavage pathways (Fig. S2H). In the MS/MS spectrometry of cinnamic acid (66) (Fig. S1J), the fragment ions with the highest abundance were observed to be m/z 103.0548 [M−H−CO2]-, which conformed to the cleavage characteristics of organic acids.

3.1.4

3.1.4 Identification of phthalides in SXXTN

Totally, 12 phthalides were tentatively identified or unambiguously authenticated, including 9 monomeric phthalides (45, 56, 108, 110, 111, 113, 122, 124) and 3 phthalide dimers (126, 127, 128). Monomeric phthalide compounds with a phthalide structure unit as the core, are prone to neutral loss of H2O, CO, CO2 and alkyl radicals or alkyl chains (CH3, C2H4, C3H6, C4H8, etc.) (Yan et al, 2022) as shown in Fig. S2I. In the MS/MS spectrometry of senkyunolide A (1 0 8), the product ion m/z 175.1123 was produced by the precursor ion loss of H2O. On this basis, the characteristic fragment m/z 147.1167 was produced by the successive loss of CO and m/z 137.0595 was the production of alkyl radical C4H8 lost by precursor ions (Fig. S1K). The phthalide dimer compounds are formed by the polymerization of two phthalide monomers. They are induced to dissociate into monomeric phthalide in MS/MS, and the highest intensity ions at m/z 191.11 are often produced (Zhang et al., 2018). Take Angelicide (1 2 8) as example, the fragment ion with highest abundance was observed at m/z 191.1066 in MS/MS spectrometry (Fig. S1L). On this basis, the cleavages of phthalide skeletons could also be observed in the MS/MS spectra of phthalide dimers, which were similar to monomeric phthalides.

3.2

3.2 GC–MS qualitative analysis of SXXTN

In preceding reports, the volatile components in SXXTN such as Artificial Musk, Chuanxiong Rhizoma, Styrax and Borneolum Syntheticum have been revealed (Ding et al., 2022; He et al., 2018; Gurbuz et al., 2013; Sun et al., 2014), whereas little attention was paid to the volatile components in the intact SXXTN prescription. In this work, we supplemented the information of volatile chemicals and improved the global characterizations of complicated ingredients in SXXTN.

The GC–MS conditions of the temperature program, splitting ratio (10:1, 30:1 and 50:1) and the injector temperature (250℃, 280℃ and 300℃) were optimized in the direction of analyzing comprehensive volatile constituents of SXXTN with well separation performance in a short analysis. The total peak area was calculated as a criterion for optimization. The final conditions were described in Section 2.4.

The TICs of SXXTN by GC–MS can be viewed in Fig. 3. There were 44 volatile compounds tentatively identified from SXXTN, based on the mass spectrometric data of reference standards, the mass spectral library (NIST17) and the literature, including 12 organic acid esters, 6 monoterpenes, 6 phthalides, 3 organic acids, 3 sesquiterpenes, 3 alcohols, 3 alkanes, 3 hydrocarbons, 2 steroids, 1 macrocyclic ketone, 1 alkaloid and 1 anhydride (Table 2). The chemical structures were illustrated in Fig. 2. Among them, seven compounds (66, 68, 110, 108, 111, 138, 46) have been identified in the previous LC-MS analysis. According to the comparison with authentic standards, 25 components were clearly marked. Isoborneol (1 4 6), borneol (1 4 8), cinnamyl alcohol (1 5 1), (E)-ligustilide (1 1 1), muscone (1 6 3), 3-phenylpropyl cinnamate (1 7 3) and cinnamyl cinnamate (1 7 4) exhibited relatively high abundances during GC–MS analysis of SXXTN.

Total ion current chromatograms of SXXTN by GC–MS.
Fig. 3
Total ion current chromatograms of SXXTN by GC–MS.
Table 2 Characterization of chemical constituents of SXXTN by GC–MS.
No. Rt (min) Identification Match Formula Structural Types
141 4.03 Glycerin 91.1 C3H8O3 Alcohol
142 5.26 Allylbenzene 82.7 C9H10 Hydrocarbon
143 7.06 Bicyclo [2,2,1] heptan-2-ol.1,5,5-trimethyl 85.2 C10H18O Monoterpenoid
144* 7.19 Fenchol 93.6 C10H18O Monoterpenoid
145* 8.19 Camphor 90.3 C10H16O Monoterpenoid
146* 8.58 Isoborneol 98.2 C10H18O Monoterpenoid
147* 8.71 Phenol, 4-ethyl- 90.7 C8H10O Phenol
148* 8.92 Borneol 97.4 C10H18O Monoterpenoid
149 9.95 Bicyclo [2.2.1] heptan-2-ol, 1,7,7-trimethyl-, (1S-endo)- 88.3 C10H18O Monoterpenoid
150* 11.31 3-Phenylpropanol 96.5 C9H12O Alcohol
151* 13.11 Cinnamyl alcohol 98.5 C9H10O Alcohol
152* 13.28 2-Methoxy-4-vinylphenol 91.4 C9H10O2 Phenol
153* 13.57 Hydrocinnamic acid 96.1 C9H10O2 Organic acid
154 13.96 1,4-Cyclohexadiene-1,2-dicarboxylic anhydride 86.5 C8H6O3 Anhydride
66* 15.27 Cinnamic acid 72.1 C9H8O2 Organic acid
155* 15.34 Caryophyllene 88.7 C15H24 Sesquiterpene
156* 16.25 Ethyl cinnamate 77.7 C11H12O2 Organic acid ester
157* 17.37 2,4-Di-tert-butylphenol 84.6 C14H22O Phenol
68* 17.66 Ethylparaben 95.1 C9H10O3 Organic acid ester
158 17.84 Δ-Cadinene 80.7 C15H24 Sesquiterpene
159* 21.84 Cadinol 91.7 C15H26O Sesquiterpene
110* 22.02 Butylphthalide 93.1 C12H14O2 Phthalide
160* 22.66 Z-Butylidenephthalide 92.4 C12H12O2 Phthalide
161 23.23 5-Pentylcyclohexa-1,3-diene 87.4 C11H18 Hydrocarbon
108* 24.06 Senkyunolide A 89.2 C12H16O2 Phthalide
162* 24.22 Neocnidilide 92.0 C12H18O2 Phthalide
111* 24.46 (E)-Ligustilide 94.9 C12H14O2 Phthalide
163* 27.32 Muscone 95.7 C16H30O Cyclic ketone
138 29.92 Palmitic acid 82.1 C16H32O2 Organic acid
164 30.36 3-Phenylpropyl benzoate 92.6 C16H22O4 Organic acid ester
165 30.69 Hexadecanoic acid, ethyl ester 88.4 C18H36O2 Organic acid ester
166 31.00 Senkyunolide H 84.1 C12H16O4 Phthalide
167 31.83 3-benzyl-1,2-dihydronaphthalene 70.3 C17H17 Hydrocarbon
168 32.86 (Z)-Cinnamyl benzoate 96.0 C16H14O2 Organic acid ester
169* 33.39 Benzyl cinnamate 95.7 C16H14O2 Organic acid ester
170 35.15 Benzenepropanoic acid, 3-phenylpropyl ester 94.3 C18H20O2 Organic acid ester
171 36.62 Borny cinnamate 91.5 C19H24O2 Organic acid ester
172 36.89 Benzenepropanoic acid, 3-phenyl-2-propenyl ester 94.8 C18H18O2 Organic acid ester
173* 38.26 3-Phenylpropyl cinnamate, (E)- 97.4 C18H18O2 Organic acid ester
174* 39.86 Cinnamyl cinnamate 97.4 C18H16O2 Organic acid ester
175* 41.40 Prasterone 76.3 C19H28O2 Steroid
176* 41.43 Androsterone 73.3 C19H30O2 Steroid
177 41.58 Phthalic acid, di(2-propylpentyl) ester 87.0 C24H38O4 Organic acid ester
46 46.06 Glaucine 89.7 C21H25NO4 Alkaloid
Compared with a reference standard.

3.3

3.3 Quantification of 40 non-volatile compounds in SXXTN by HPLC-QQQ MS

Forty confirmed non-volatile chemicals were further quantified by the optimized HPLC-QQQ MS method (Table S3-S4) to evaluate the quality of SXXTN. According to the difference in the response of the components in positive and negative ion modes, two MRM methods with different polarity were established for Quantification. The typical MRM chromatograms of analytes were illustrated in Fig S3.

Nice linearity with coefficients of determination (R2 > 0.9900) were obtained for the 40 analytes. Limit of detection (LOD) and limit of quantitation (LOQ) tests were performed and listed in Table S7. As exhibited in Table S8, relative standard deviations (RSD) of repeatability, intra- and inter-day precision were 1.27 % − 4.79 %, 1.07 % − 5.41 % and 1.18 % − 9.43 %, respectively. Besides, all analytes could remain stable within 24 h under 4℃, with the RSD ranging 0.60 % − 6.14 % and recoveries of 40 compounds were ranged from 80.36 % − 117.13 % with the RSD ranging 2.38 % − 12.61 %. Consequently, the established HPLC-QQQ MS approach was proved as a sensitive, repeatable and accurate tool for the quantification of non-volatile compounds in SXXTN.

According to the established HPLC-QQQ MS quantitative analysis method, the content of 40 compounds in 7 batches of SXXTN provided by the enterprise was determined as shown in Table 3 and Fig. 4. The total content of 40 analytes in each batch was 2.03 % − 2.30 %. Among them, the components with higher content (>1.00 mg/g) were norglaucine (43), glaucine (46), dehydrocorydaline (75) and ginsenoside Rb1 (86). In the previous reported, aforementioned compounds presented promising effects for myocardial protection (Wen et al., 2022; Han et al., 2012; Zheng et al., 2017; Kong et al., 2018). For example, studies have found that intraperitoneal injection of dehydrocorydine in ApoE-/- mice can not only inhibit the development of atherosclerosis, but also improve aortic compliance and plaque stability (Wen et al., 2022). Tetrahydropalmatine can activate PI3K/Akt/eNOS/NO pathway, increase the expression of HIF-1a and VEGF, and inhibit iNOS-derived NO production in myocardium. This effect may reduce the accumulation of inflammatory factors (including TNF-a and MPO) and reduce the degree of apoptosis (Han et al., 2012). It has also been reported that ginsenoside Rb1 can improve heart failure, which may be achieved by regulating the mitochondrial membrane in cardiomyocytes (Kong et al., 2018).

Table 3 Contents of 57 analytes determined in SXXTN samples by HPLC-QQQ MS and GC-QQQ MS (μg/g, Mean ± SD, n = 3).
No. Components B1 B2 B3 B4 B5 B6 B7
non-volatile components
5 Phenylalanine 86.83 ± 2.32 86.5 ± 3.25 64.25 ± 6.71 61.17 ± 5.4 29.33 ± 2.88 20.92 ± 1.01 85.92 ± 7.67
6 Tetramethylpyrazine 1.36 ± 0.05 1.47 ± 0.13 2.28 ± 0.05 1.5 ± 0.08 2.64 ± 0.05 3.14 ± 0.05 3.19 ± 0.05
21 Scoulerine 65.31 ± 6.33 71.92 ± 2.5 82.53 ± 2.59 74.67 ± 1.67 103.25 ± 5.29 107.08 ± 6.98 107.58 ± 2.62
23 Isocorydine 17.97 ± 0.65 19.44 ± 0.46 20.53 ± 0.67 19.72 ± 0.61 28.89 ± 0.68 28.97 ± 0.47 29.72 ± 0.57
28 Corydalmine 47.47 ± 1.46 50.17 ± 1.52 56.75 ± 1.18 51.81 ± 0.77 51.25 ± 4.1 51.67 ± 2.82 51.53 ± 1.5
29 Tetrahydrocolumbamie 631.94 ± 12.95 621.94 ± 38.75 710.56 ± 17 602.22 ± 9.18 988.89 ± 26.79 1043.61 ± 2.55 1040.56 ± 44.92
33 Corypalmine 68.64 ± 0.6 73.22 ± 2.53 78.36 ± 1.64 75.42 ± 2.3 127.64 ± 1.77 137.22 ± 5.23 133.61 ± 3.72
36 Protopine 849.11 ± 12.48 869.92 ± 34.43 935.56 ± 35.06 860.64 ± 15.65 1062.14 ± 19.22 1125.22 ± 42.62 1125.03 ± 27.57
37 Demethyleneberberine 8.14 ± 0.05 8.5 ± 0.36 9.22 ± 0.21 8.58 ± 0.17 7.81 ± 0.13 8.25 ± 0.17 8.11 ± 0.34
43 Norglaucine 10063.33±
154.52
9121.39±
263.53
9767.78±
337.78
8266.94±
90.49
7842.22±
509.16
7953.89±
104.36
8121.94±
194.84
44 Allocryptopine 544.53 ± 27.26 534.5 ± 14.24 575.03 ± 20.11 530.03 ± 13.11 631.28 ± 27.8 672.31 ± 28.3 684.06 ± 22.77
46 Glaucine 910 ± 5.46 955.56 ± 31.9 1068.33 ± 48.18 929.44 ± 9.66 1009.17 ± 88.93 1036.11 ± 14.82 1061.11 ± 29.27
48 Tetrahydropalmatine 432.22 ± 14.2 422.78 ± 18.95 486.94 ± 22.12 418.89 ± 8.67 646.39 ± 57.4 674.17 ± 11.67 683.61 ± 12.48
52 Coptisin 513.14 ± 18.5 533.58 ± 19.6 631.47 ± 17.92 528.25 ± 20.18 683.81 ± 46.08 770.03 ± 47.76 768.31 ± 12.25
53 Columbamine 414.25 ± 8.33 426.61 ± 12.44 466.33 ± 14.99 422.61 ± 18.19 385.47 ± 25.7 417.39 ± 23.39 418.83 ± 8.24
55 Jatrorrhizine 24.75 ± 2.32 24.64 ± 3.56 28.42 ± 1.98 26.58 ± 1.69 28.64 ± 2.79 31.25 ± 2.35 32.92 ± 1.08
58 Canadine 103.61 ± 3.37 103.33 ± 3.63 120.28 ± 2.41 104.72 ± 0.48 171.39 ± 12.14 183.89 ± 2.55 183.89 ± 2.55
60 Corydaline 445.28 ± 11.71 455.83 ± 15.83 537.22 ± 17.02 443.89 ± 5.55 839.17 ± 50.26 885 ± 23.11 897.78 ± 7.74
66 Cinnamic acid 482.5 ± 15.52 529.5 ± 20.11 505 ± 31.83 515.33 ± 16.33 477.33 ± 14.1 515.25 ± 17.37 308.08 ± 18.32
67 Notoginsenoside R1 50.25 ± 0.25 53.58 ± 1.28 50.83 ± 4.94 49.25 ± 2.7 24.75 ± 2.14 26.25 ± 1.39 23.08 ± 1.01
70 Berberine 171.39 ± 4.86 176.39 ± 2.51 190.11 ± 4.03 170.92 ± 0.75 197.5 ± 4.01 203.06 ± 4.76 201.83 ± 2.35
71 Palmatine 588.44 ± 12.35 603.11 ± 6.88 638.22 ± 13.26 581.14 ± 4.43 540.64 ± 9.63 560.03 ± 13.97 555.5 ± 2.28
73 Ginsenoside Rg1 803.67 ± 14.68 831.42 ± 17.47 777.58 ± 34.06 731.5 ± 37.15 929.33 ± 27.19 915.58 ± 18.06 867.67 ± 54.56
74 Ginsenoside Re 565.17 ± 19.12 579.67 ± 36.71 547.42 ± 43.84 521.58 ± 32.77 559.42 ± 23.51 562.67 ± 11.2 826.83 ± 81.78
75 Dehydrocorydaline 1666.11 ± 18.15 1677.22 ± 49.14 1840.28 ± 40.79 1677.22 ± 25.69 1548.06 ± 73.42 1607.5 ± 28.83 1554.44 ± 17.8
76 13-Methylberberine 11.92 ± 0.17 11.92 ± 0.17 12.89 ± 0.24 11.81 ± 0.05 8.58 ± 0.14 8.86 ± 0.1 9 ± 0.08
80 Ginsenoside Rf 102 ± 3.36 111 ± 7.15 102.83 ± 10.26 90.5 ± 6.43 135.25 ± 3.5 135.83 ± 7.52 108.08 ± 6.79
83 Ginsenoside Rg2 92.83 ± 2.74 98.42 ± 5.84 96.58 ± 7.38 90 ± 2.61 77.25 ± 1.32 79 ± 2.84 60.92 ± 3.17
84 Ginsenoside Ra2 71.83 ± 1.91 74.25 ± 2.82 76.33 ± 3.4 72 ± 2.14 83.67 ± 0.88 84.67 ± 1.91 80.17 ± 1.89
85 Ginsenoside Ra3 211 ± 0.43 199.25 ± 16.69 190.67 ± 3.39 188.33 ± 9.7 203.92 ± 3.69 214.67 ± 6.57 290.83 ± 27.19
86 Ginsenoside Rb1 1025.25 ± 6.51 1045.08 ± 54.55 1030.92 ± 80.79 960.92 ± 29.16 708.08 ± 22.64 716.33 ± 15.95 571.33 ± 22.92
88 Ginsenoside Rc 281.42 ± 4.23 294.17 ± 8.08 288.5 ± 13.56 267.58 ± 8.38 227.75 ± 0.9 226.5 ± 0.66 221.58 ± 10.04
89 Ginsenoside Ra1 155.58 ± 3.83 167.67 ± 9.87 169.25 ± 10.4 148.33 ± 3.22 184.5 ± 9.79 187.33 ± 7.04 180.58 ± 5.11
93 Ginsenoside Rb2 379.33 ± 7.69 398.17 ± 20.89 394.67 ± 31.29 357.75 ± 12.89 282.5 ± 12.67 281.42 ± 5.58 225.75 ± 5.91
94 Ginsenoside Rb3 37.75 ± 1 39.17 ± 2.01 41.75 ± 3.12 34.33 ± 2.7 24.5 ± 2.41 24.42 ± 0.95 227.75 ± 6.71
101 Ginsenoside Rd 248.33 ± 10.47 261.92 ± 8.61 261.25 ± 20.12 236.75 ± 9.85 178.5 ± 7.7 180.17 ± 4.69 142.25 ± 6.29
107 8-Oxycoptisine 27.08 ± 3.18 25.36 ± 0.67 27.75 ± 0.38 25.06 ± 0.38 27.81 ± 0.42 28.86 ± 0.27 28 ± 0.38
116 20(S)-Ginsenoside Rg3 57.67 ± 2.36 65.42 ± 3.15 64.58 ± 1.42 60.08 ± 2.47 15.83 ± 0.14 15.33 ± 0.38 14.5 ± 0.5
120 Dihydrochelerythrine 36.69 ± 4.46 34.36 ± 0.87 36.33 ± 0.22 35.44 ± 0.59 49.53 ± 0.63 49.08 ± 0.33 49.64 ± 0.79
123 Dihydrosanguinarine 31.5 ± 2.58 32 ± 0.58 34.17 ± 0.46 32.89 ± 0.42 45.86 ± 0.21 46.67 ± 0.38 45.5 ± 0.87
volatile components
144 Fenchol 31.79 ± 0.72 24.14 ± 0.74 31.36 ± 0.23 28.89 ± 1.00 132.64 ± 1.08 233.88 ± 1.23 212.26 ± 0.61
145 Camphor 122.36 ± 0.58 99.94 ± 1.17 130.70 ± 0.35 115.32 ± 0.86 40.82 ± 0.14 78.08 ± 1.08 67.93 ± 0.08
146 Isoborneol 10746.58 ± 56.15 8297.41 ± 30.66 10784.14 ± 10.58 11041.49 ± 41.12 6992.38 ± 22.46 10192.18 ± 55.59 10537.26 ± 85.96
147 4-Ethylphenol 111.73 ± 2.12 101.78 ± 2.15 110.57 ± 0.64 107.77 ± 1.56 92.31 ± 5.60 122.53 ± 3.56 120.49 ± 0.66
148 Borneol 16154.89 ± 17.28 12716.32 ± 71.79 16158.12 ± 26.98 16557.61 ± 73.28 11800.29 ± 15.21 15303.33 ± 71.80 16110.40 ± 39.41
150 3-Phenylpropanol 287.24 ± 5.17 269.94 ± 5.95 295.45 ± 2.43 282.39 ± 4.51 323.49 ± 4.19 342.09 ± 10.25 332.53 ± 1.81
151 Cinnamyl alcohol 677.68 ± 11.97 659.66 ± 7.87 687.77 ± 9.42 676.31 ± 1.38 775.47 ± 15.66 782.07 ± 17.59 775.85 ± 9.96
155 Caryophyllene 99.41 ± 0.63 88.88 ± 0.23 101.31 ± 0.57 96.25 ± 1.05 68.95 ± 0.09 108.27 ± 0.63 102.55 ± 0.62
110 Butylphthalide 120.17 ± 0.72 119.28 ± 0.8 120.54 ± 0.52 118.96 ± 0.03 175.46 ± 0.95 166.65 ± 0.62 166.47 ± 0.78
160 Z-Buthlidenephthalide 470.46 ± 8.24 461.27 ± 6.60 469.83 ± 4.71 462.35 ± 5.09 918.91 ± 4.81 838.41 ± 5.49 834.35 ± 3.20
108 Senkyunolide A 445.75 ± 1.01 445.75 ± 5.70 453.88 ± 4.66 436.02 ± 2.77 1001.42 ± 2.58 963.05 ± 5.76 953.08 ± 6.39
162 Neocnidilide 114.94 ± 0.39 111.39 ± 1.46 112.35 ± 0.51 111.00 ± 0.5 209.89 ± 0.45 195.90 ± 0.17 196.40 ± 1.01
111 (E)-Ligustilide 708.93 ± 4.13 683.43 ± 5.57 698.54 ± 2.74 689.34 ± 2.44 1470.36 ± 15.50 1400.27 ± 10.26 1388.91 ± 5.15
163 Muscone 1185.77 ± 14.67 1092.55 ± 4.44 1174.19 ± 3.1 1145.85 ± 16.89 1258.91 ± 21.03 1206.96 ± 16.67 1173.77 ± 4.76
169 Benzyl cinnamate 663.55 ± 3.06 634.83 ± 5.35 664.60 ± 2.63 652.38 ± 1.63 694.71 ± 2.69 689.84 ± 4.29 665.64 ± 1.52
173 3-Phenylpropyl Cinnamate 3532.42 ± 24.74 3194.93 ± 115.13 3503.38 ± 37.00 3493.68 ± 142.94 3855.59 ± 47.58 3730.66 ± 119.27 3828.99 ± 29.46
174 Cinnamyl cinnamate 4781.76 ± 48.54 4442.54 ± 117.11 4790.28 ± 38.97 4753.69 ± 164.10 5193.83 ± 65.96 4995.83 ± 171.5 5131.81 ± 42.73
The content distribution heatmap of 40 non-volatile compounds in 7 batches of SXXTN.
Fig. 4
The content distribution heatmap of 40 non-volatile compounds in 7 batches of SXXTN.

3.4

3.4 Quantification of 17 volatile compounds in SXXTN by GC-QQQ MS

We established rapid and accurate quantitative methods for detecting the contents of the major volatile compounds in SXXTN. Seventeen confirmed compounds including 5 phthalides, 3 organic acid esters, 3 alcohols, 3 monoterpenes, 1 sesquiterpene, 1 phenol and 1 macrocyclic ketone were determined by GC-QQQ MS with naphthalene (IS3) as internal standards. The optimized conditions were shown in Table S5-S6 and typical MRM chromatograms of 17 analytes were illustrated in Fig S4.

The optimized GC-QQQ MS method was validated in the aspect of linearity, LODs, LOQs, precision, repeatability, stability and recovery and the results were presented in Table S9 and Table S10. Reasonable correlation coefficient values (R2 > 0.9904) indicated good correlations between investigated standards concentrations and their peak areas within the ranges tested. The ranges of LODs and LOQs for all the analytes were 0.002 - 2.642 μg/mL, and 0.013 – 6.653 μg/mL, respectively. The RSDs of repeatability, intra- and inter-day precision were 1.63% - 9.66%, 0.44% – 9.06%, 0.80% – 8.06%, respectively. All analytes could remain stable within 24 h under 4℃, with the RSD ranging 1.14% - 7.97%. The developed method had good accuracy with the recoveries were between 90.20% and 123.51%. These results provided that the established method was accurate, reproducible, and reliable for assessing the quality of volatile compounds in SXXTN.

According to the established GC-QQQ MS quantitative analysis method, the contents of main volatile components in 7 batches of SXXTN provided by the enterprise were determined as displayed in Table 3 and Fig. 5. The total content of analytes in each batch was 3.34 %-4.26 % in SXXTN. Borneol (1 4 6), isoborneol (1 4 8), cinnamyl cinnamate (1 7 4), 3-phenylpropyl cinnamate (1 7 3) and muscone (1 6 3) were the predominant components and were closely related to the anti-coronary heart disease and angina pectoris effect of SXXTN (Liu et al., 2017; Wu et al., 2011; Wang et al., 2020).

The content distribution heatmap of 17 volatile compounds in 7 batches of SXXTN.
Fig. 5
The content distribution heatmap of 17 volatile compounds in 7 batches of SXXTN.

Combined with the quantitative analysis of non-volatile components, the total contents of 57 main components in 7 batches of SXXTN were 5.50 % − 6.49 %. The percentages of different structural types of chemicals in the total 57 analytes were as follows: monoterpenes and sesquiterpenes accounted for the largest proportion (42 %), followed by alkaloids (26 %), organic acids and esters (18 %), ginsenosides (6 %) and phthalide (5 %). Both volatile and non-volatile components should be taken into consideration for quality evaluation of SXXTN. More batches of samples are more conducive to assessing the consistency and stability of SXXTN.

4

4 Conclusion

In view of the current deficiencies in the constituent research and quality control of SXXTN, efficient, stable and reliable LC-MS and GC–MS methods were established in our study. A total of 177 chemical components were identified from SXXTN and content of 57 components in 7 batches of SXXTN was further determined. To the best of our knowledge, this is the initial report on the comprehensive profiling of chemical constituents in SXXTN by LC-MS and GC–MS. The evaluation approach provided much more qualitative and quantitative information of multi-components in SXXTN than other single-marker quality assessments. In all, this study provided comprehensive material basis of SXXTN, which could be beneficial to improve the quality control. Furthermore, it could facilitate the pharmacological research and clinical application of SXXTN in some degree.

Acknowledgements

The authors sincerely thank Hui-Ying Wang (State Key Laboratory of Natural Medicines, China) for the technical assistance.

Funding

This work was financially supported by the National Natural Science Foundation of China (No. 81730104).

Declaration of Competing Interest

The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.

References

  1. , , , , , , , , , . From non-targeted to targeted GC-MS metabolomics strategy for identification of TCM preparations containing natural and artificial musk. Chin. Med.. 2022;17:41.
    [Google Scholar]
  2. , , , , , , . Characterization of volatiles and anti-ulcerogenic effect of Turkish sweetgum balsam (Styrax liquidus) J. Ethnopharmacol.. 2013;148:332-336.
    [Google Scholar]
  3. , , , , , , , , , , , , . l-Tetrahydropalmatine, an Active Component of Corydalis yanhusuo W.T. Wang, Protects against Myocardial Ischaemia-Reperfusion Injury in Rats. PLoS. One.. 2012;7:e38627.
    [Google Scholar]
  4. , , , , , , . A modified multiscale peak alignment method combined with trilinear decomposition to study the volatile/heat-labile components in Ligusticum chuanxiong Hort - Cyperus rotundus rhizomes by HS-SPME-GC/MS. J. Chromatogr. B. Analyt. Technol. Biomed. Life. Sci.. 2018;1079:41-50.
    [Google Scholar]
  5. , , , , , , . The effects of ginsenoside Rb1 on fatty acid β-oxidation, mediated by AMPK, in the failing heart. Iran. J. Basic. Med. Sci.. 2018;21:731-737.
    [Google Scholar]
  6. , , , , , , , , , . Chinese Medicine She-Xiang-Xin-Tong-Ning, Containing Moschus, Corydalis and Ginseng, Protects from Myocardial Ischemia Injury via Angiogenesis. Am. J. Chin. Med.. 2020;48:107-126.
    [Google Scholar]
  7. , , , . Comparison of the therapeutic effects of different compositions of muskone in the treatment of experimental myocardial infarct in rats and analgesia in mice. Phytother. Res.. 2008;22:1219-1223.
    [Google Scholar]
  8. , , , . Corydalis yanhusuo rhizoma extract reduces infarct size and improves heart function during myocardial ischemia/reperfusion by inhibiting apoptosis in rats. Phytother. Res.. 2010;20:448-453.
    [Google Scholar]
  9. , , , , , , , , . Four Main Active Ingredients Derived from a Traditional Chinese Medicine Guanxin Shutong Capsule Cause Cardioprotection during Myocardial Ischemia Injury Calcium Overload Suppression. Phytother. Res.. 2017;31(3):507-515.
    [Google Scholar]
  10. , , , , , . Screening of Bioactive Ingredients in Ligusticum Chuanxiong Hort for Protection against Myocardial Ischemia. Cell. Physiol. Biochem.. 2016;40:770-780.
    [Google Scholar]
  11. , , , , , . Rapid identification and analysis of the active components of traditional Chinese medicine Xiaoxuming decoction for ischemic stroke treatment by integrating HPLC-Q-TOF/MS and RRLC-QTRAP MSn method. J. Chromatogr. B. Analyt. Technol. Biomed. Life. Sci.. 2019;1124:313-322.
    [Google Scholar]
  12. , , . Observation of the Blood Rheology and Clinical Effects of Shexiangxintongning tablet on 60 Cases with Coronary Heart Disease Combined with Angina Pectoris. Chin. J. Nat. Med.. 2005;7:114-117.
    [Google Scholar]
  13. , , , , , , , , . Hypothesis of active components in volatile oil from a Chinese herb formulation, Shao-Fu-Zhu-Yu decoction, using GC-MS and chemometrics. J. Sep. Sci.. 2008;31(6–7):1085-1091.
    [Google Scholar]
  14. , , , , , . Simultaneous determination of borneol and its metabolite in rat plasma by GC-MS and its application to pharmacokinetic study. J. Pharm. Anal.. 2014;4(5):345-350.
    [Google Scholar]
  15. , , , . Discussion on efficacy evaluation thought and method for innovation medicine of Chinese herbal compound formula based on clinical application characteristics. Zhongguo Zhongyao Zazhi.. 2017;42(5):852-855.
    [Google Scholar]
  16. , , . Relationship between dose and effects of Suhexiang against myocardial ischemia of model rats. Acta Chin. Med.. 2019;34:2157-2163.
    [Google Scholar]
  17. , , , , , , , . Isoborneol Attenuates Low-Density Lipoprotein Accumulation and Foam Cell Formation in Macrophages. Drug Des. Dev. Ther.. 2020;14:167-173.
    [Google Scholar]
  18. , , , , , , , , , , , , , . Rapid analysis on phenolic compounds in Rheum palmatum based on HPLC-Q-TOF/MSE combined with diagnostic ions filter. China J. Chin. Mater. Med.. 2017;42(10):1922-1931.
    [Google Scholar]
  19. , , , , , , , , . Antiatherosclerotic effect of dehydrocorydaline on ApoE(-/-) mice: inhibition of macrophage inflammation. Acta. Pharmacol. Sin.. 2022;6:1408-1418.
    [Google Scholar]
  20. , , , , , , , . Protective effects of muscone on ischemia-reperfusion injury in cardiac myocytes. J. Ethnopharmacol.. 2011;138(1):34-39.
    [Google Scholar]
  21. , , , , , , , , , . Chemical profiling and quantification of Gua-Lou-Gui-Zhi decoction by high performance liquid chromatography/quadrupole-time-of-flight mass spectrometry and ultra-performance liquid chromatography/triple quadrupole mass spectrometry. J. Ethnopharmacol.. 2015;138(1):34-39.
    [Google Scholar]
  22. , , . Analysis on chemical constituents in Danggui-Shaoyao-San by LC-Q-TOF-MS and LC-IT-MSn. Chin. Tradit. Herb. Drugs. 2014;45(8):1056-1062.
    [Google Scholar]
  23. , , , , , , , , , . A comprehensive investigation on the chemical diversity and efficacy of different parts of Ligusticum chuanxiong. Food. Funct.. 2022;13:1092-1107.
    [Google Scholar]
  24. , , , , , , , . Localization of constituents for determining the age and parts of ginseng through ultraperfomance liquid chromatography quadrupole/time of flight-mass spectrometry combined with desorption electrospray ionization mass spectrometry imaging. J. Pharm. Biomed. Anal.. 2021;193:113722
    [Google Scholar]
  25. , , , , , , , , . The classification and identification of complex chemical compositions based on UPLC-Q-TOF/MS using yanhusuo herb as an example. Anal. Methods.. 2016;8(10):2274-2281.
    [Google Scholar]
  26. , , , , , . A strategy to improve the identification reliability of the chemical constituents by high-resolution mass spectrometry-based isomer structure prediction combined with a quantitative structure retention relationship analysis: Phthalide compounds in Chuanxiong as a test case. J. Chromatogr. A.. 2018;1552:17-28.
    [Google Scholar]
  27. , , , , , , , , , . (+)-Borneol improves the efficacy of edaravone against DSS-induced colitis by promoting M2 macrophages polarization via JAK2-STAT3 signaling pathway. Int. Immunopharmacol.. 2017;53:1-10.
    [Google Scholar]
  28. , , , , , , , , . A detection method for Shexiangxintongning preparation. CN104897811B. 2016
    [Google Scholar]
  29. , , , , , , , . Ginsenoside Rb1 improves cardiac function and remodeling in heart failure. Exp. Anim.. 2017;66(3):217-228.
    [Google Scholar]
  30. , , , . Roles and mechanisms of ginseng in protecting heart. Chin. J. Integr. Med.. 2012;18:548-555.
    [Google Scholar]
  31. , , , , , , , . Study on the discrimination between Corydalis Rhizoma and its adulterants based on HPLC-DAD-Q-TOF-MS associated with chemometric analysis. J. Chromatogr. B.. 2018;1090:110-121.
    [Google Scholar]

Appendix A

Supplementary material

Supplementary data to this article can be found online at https://doi.org/10.1016/j.arabjc.2022.104527.

Appendix A

Supplementary material

The following are the Supplementary data to this article:

Supplementary data 1

Supplementary data 1

Show Sections